{
    "clinical_study": {
        "@rank": "65580", 
        "arm_group": [
            {
                "arm_group_label": "HFCWO", 
                "arm_group_type": "Experimental", 
                "description": "HFCWO for 15 min twice a day"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "not to receive high-frequency chest wall oscillation (HFCWO)"
            }
        ], 
        "brief_summary": {
            "textblock": "The effectiveness, safety and tolerance/comfort of high-frequency chest wall oscillation\n      (HFCWO) in prolonged mechanical ventilation patients remain unknown. This study aimed to\n      test the hypothesis that HFCWO could produce greater clearance volume of sputum, greater\n      improvement rates in serial changes in the chest X-ray (CXR), and greater weaning success\n      rates after extubation in Prolonged Mechanical Ventilation (PMV) patients with\n      intra-tracheal intubation."
        }, 
        "brief_title": "HFCWO in Prolonged Mechanical Ventilation Patients", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Ventilator Dependency", 
        "detailed_description": {
            "textblock": "For over 20 years, studies have attempted to examine the effectiveness, safety and\n      tolerance/comfort of HFCWO in the management of surgical and non-surgical patients who had\n      impaired bronchial secretion clearance, including those with neuromuscular disorders,\n      chronic obstructive pulmonary disease, cystic fibrosis, and blunt thoracic trauma, or those\n      hospitalized for critical cardiac/abdominal/thoracic surgery. However, these outcomes of\n      HFCWO on PMV patients remain unknown.\n\n      This parallel-design, randomized controlled trial aimed to test the hypothesis that HFCWO\n      could produce greater clearance volume of sputum, greater improvement rates in serial\n      changes in the chest X-ray (CXR), and greater weaning success rates after extubation in PMV\n      patients with intra-tracheal intubation. Moreover, the safety and tolerance/comfort of HFCWO\n      in PMV patients after removal of endotracheal tubes were also evaluated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. continuous intra-tracheal intubation and mechanical ventilator support for at least\n             21 days\n\n          2. age \u226520 year-old\n\n          3. having an acute or chronic pulmonary condition requiring secretion mobilization as\n             judged by the physician\n\n          4. alert consciousness; completion of the Modified Borg Scale (MBS) and Hamilton Anxiety\n             Scale (HAS)\n\n          5. scheduled extubation within 24 hours after enrollment\n\n          6. without any contraindication for HFCWO (i.e., recent spinal injuries which have not\n             yet been stabilized and active hemorrhage with hemodynamic instability)\n\n        Exclusion Criteria:\n\n        1. those who had undergone tracheostomy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "45", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02077738", 
            "org_study_id": "C10216", 
            "secondary_id": "huang5598"
        }, 
        "intervention": {
            "arm_group_label": "HFCWO", 
            "description": "study subjects in the HFCWO group received HFCWO for 15 min twice a day for 5 days after extubation", 
            "intervention_name": "HFCWO (Hill-Rom Vest\u2122 Airway Clearance System)", 
            "intervention_type": "Device", 
            "other_name": "Hill-Rom Vest\u2122 Airway Clearance System"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "effectiveness", 
            "elderly", 
            "high frequency chest wall oscillation", 
            "mechanical ventilation", 
            "pneumonia", 
            "randomized controlled trial"
        ], 
        "lastchanged_date": "March 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Taichung", 
                    "country": "Taiwan", 
                    "zip": "40705"
                }, 
                "name": "Taichung Veterans General Hospital"
            }
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_arms": "2", 
        "official_title": "High-frequency Chest Wall Oscillation in Prolonged Mechanical Ventilation Patients-a Randomized Controlled Trial", 
        "overall_official": {
            "affiliation": "Taichung Veterans General Hospital", 
            "last_name": "Chieh-Liang Wu, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Taiwan: Ministry of Health and Welfare", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Successful weaning was defined as continuous liberation from mechanical ventilator support longer than 5 days.", 
                "measure": "Effectiveness as determined by weaning success rates", 
                "safety_issue": "No", 
                "time_frame": "up to 5 days after extubation"
            }, 
            {
                "description": "The daily clearance volume of sputum was determined by the numbers of sputum suction per day", 
                "measure": "Effectiveness as determined by daily clearance volume of sputum", 
                "safety_issue": "No", 
                "time_frame": "up to 5 days after extubation"
            }, 
            {
                "description": "The sputum coloration was determined by the Color Card for Body Fluid (CCBF). The CCBF was designed to have 27 different categories to describe the color of the body fluid. Each category was assigned an Arabic numeral and the larger the Arabic numeral, the darker the color of the body fluid. The scoring of sputum coloration was based on the perception of the interviewer who was blinded to the intervention.", 
                "measure": "Effectiveness as determined by serial changes in sputum coloration", 
                "safety_issue": "No", 
                "time_frame": "up to 5 days after extubation"
            }, 
            {
                "description": "Baseline and follow-up CXRs were taken on the day of extubation and on the 5th day after extubation, respectively, in both groups. Serial changes in CXR were graded as \"improved\", \"no change\", or \"progressed\", as determined by the severity of lung infiltrates, which were defined by two independent chest specialists blinded to the study groupings. If no consistency between two specialists, the grading would be judged by the third chest specialist.", 
                "measure": "Effectiveness as determined by chest X-ray improvement rates", 
                "safety_issue": "No", 
                "time_frame": "up to 5 days after extubation"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02077738"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Taichung Veterans General Hospital", 
            "investigator_full_name": "TCVGH", 
            "investigator_title": "Taichung Veterans General Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "systolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded before and after each HFCWO treatment by nurses who were unblinded to the study groupings.", 
                "measure": "safety as determined by the changes of blood pressures before and after HFCWO", 
                "safety_issue": "Yes", 
                "time_frame": "up to 5 days after extubation"
            }, 
            {
                "description": "Heart rates (HR) was recorded before and after each HFCWO treatment by nurses who were unblinded to the study groupings.", 
                "measure": "safety as determined by the changes of  heart rates before and after HFCWO", 
                "safety_issue": "Yes", 
                "time_frame": "up to 5 days after extubation"
            }, 
            {
                "description": "Respiratory rates (RR) were recorded before and after each HFCWO treatment by nurses who were unblinded to the study groupings.", 
                "measure": "safety as determined by the changes of  respiratory rates (RR) before and after HFCWO", 
                "safety_issue": "Yes", 
                "time_frame": "up to 5 days after extubation"
            }, 
            {
                "description": "Oxyhemoglobin saturations by pulse oximetry (SpO2) were recorded before and after each HFCWO treatment by nurses who were unblinded to the study groupings.", 
                "measure": "safety as determined by the changes of  oxyhemoglobin saturations by pulse oximetry (SpO2)  before and after HFCWO", 
                "safety_issue": "Yes", 
                "time_frame": "up to 5 days after extubation"
            }, 
            {
                "description": "MBS was measured before and after treatment in HFCWO group and at the same time in non-HFCWO group by the interviewer who was blinded to the intervention from the day of extubation to the 5th post-extubation day.", 
                "measure": "tolerance/comfort as determined by Modified Borg Scale (MBS)", 
                "safety_issue": "No", 
                "time_frame": "up to 5 days after extubation"
            }, 
            {
                "description": "HAS was measured before and after treatment in HFCWO group and at the same time in non-HFCWO group by the interviewer who was blinded to the intervention from the day of extubation to the 5th post-extubation day.", 
                "measure": "tolerance/comfort as determined by Hamilton Anxiety Scale (HAS)", 
                "safety_issue": "No", 
                "time_frame": "up to 5 days after extubation"
            }
        ], 
        "source": "Taichung Veterans General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Taichung Veterans General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}